We hypothesize that AI-assisted colonoscopy can reduce post-colonoscopy neoplasia incidence after 3 years, over standard colonoscopy. Moreover, this protective effect may allow surveillance intervals to be lengthened, by modifying long-term outcome of high-risk subgroup.
None
None
Single group
ENDO-AID CADe
DeviceENDO-AID CADe will be used during the withdrawal process of the colonscopy
Post-colonoscopy adenomas at year 3
The primary endpoint is the incidence of post-colonoscopy adenomas at year 3, which is the composite of new occurrence and metachronous recurrence of adenomas during surveillance.
Post-colonoscopy AA
Incidence of post-colonoscopy advanced adenomas
Post-colonoscopy advanced neoplasms
Incidence of post-colonoscopy advanced neoplasms
Post-colonoscopy SSL
Incidence of post-colonoscopy SSL
Post-colonoscopy CRC
Incidence of post-colonoscopy CRC
Click on the lead sponsor to view all of their trials.
